Oculus Innovative Sciences, Inc.' Partner, More Pharma Corporation, Launches Microcyn®-Based Oral And Throat Infection Treatment Product In Mexico

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PETALUMA, Calif., April 22, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 33 countries, today announced the commercialization in Mexico of the first product under the Microdacyn60® Oral Care brand intended for use as an adjunct treatment in both mouth and throat infections. Commercialized under the brand name Microdacyn60™ Bucofaringeo™, it is now available in Mexican pharmacies. At the same time, the More Pharma sales team is introducing the treatment to general practitioners along with ear, nose and throat specialists throughout Mexico.

Help employers find you! Check out all the jobs and post your resume.

Back to news